NEW YORK (GenomeWeb News) – BioTrove has filed with the US Securities and Exchange Commission to offer an undetermined number of its shares in an initial public offering.
 
The preliminary prospectus for the IPO did not provide an estimated range for the offering price. BioTrove expects to float on the Nasdaq and trade under the symbol “BTRV.”
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.